MedPath

Characterization of Cancer Tissue Using 3D Biosynthetic Material

Conditions
Cancer
Registration Number
NCT02678078
Lead Sponsor
Technion, Israel Institute of Technology
Brief Summary

Characterization of Cancer Tissue Using 3D Biosynthetic Materials. Using liver biopsy from stage 4 cancer patients, the investigators will evaluate and characterize the metastatic cells.

Detailed Description

The investigators' biomaterial lab has developed an in vitro diagnostic system in which a cancer tumor is placed inside a 3D hydrogel. This material has similar properties to the human tissue and can visualize cell migration and proliferation. In this system, the investigators have already characterised human metastatic cells obtained from nude mice tumors. The diagnostic assay is able to evaluate the reduction in cell growth associated with anti-cancer drug therapy. The next step is to test the in vitro diagnostic system using human tissue samples from human patients, and to validate the system as a simple and effective a priori diagnostic tool for characterizing patient tumours.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • liver tumor
Exclusion Criteria
  • refuse to volunteer

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
cell growth1 week

biopsy will be placed inside 3D gel, and growth will be measured over 1 week time.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rambam

🇮🇱

Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath